Plasma homoarginine, arginine, asymmetric dimethylarginine and total homocysteine interrelationships in rheumatoid arthritis, coronary artery disease and peripheral artery occlusion disease

Research output: Contribution to journalArticleResearchpeer review

Authors

  • A.A. Kayacelebi
  • J. Willers
  • V.V. Pham
  • Andreas Hahn
  • J.Y. Schneider
  • S. Rothmann
  • J.C. Frölich
  • D. Tsikas

External Research Organisations

  • Hannover Medical School (MHH)
  • Zentrum Pharmakologie und Toxikologie
View graph of relations

Details

Original languageEnglish
Pages (from-to)1885-1891
Number of pages7
JournalAMINO ACIDS
Volume47
Issue number9
Publication statusPublished - 28 Sept 2015

Abstract

Elevated circulating concentrations of total L-homocysteine (thCys) and free asymmetric dimethylarginine (ADMA) are long-established cardiovascular risk factors. Low circulating L-homoarginine (hArg) concentrations were recently found to be associated with increased cardiovascular morbidity and mortality. The biochemical pathways of these amino acids overlap and share the same cofactor S-adenosylmethionine (SAM). In the present study, we investigated potential associations between hArg, L-arginine (Arg), ADMA and thCys in plasma of patients suffering from rheumatoid arthritis (RA), coronary artery disease (CAD) or peripheral artery occlusive disease (PAOD). In RA, we did not find any correlation between ADMA or hArg and thCys at baseline (n = 100) and after (n = 83) combined add-on supplementation of omega-3 fatty acids, vitamin E, vitamin A, copper, and selenium, or placebo (soy oil). ADMA correlated with Arg at baseline (r = 0.446, P < 0.001) and after treatment (r = 0.246, P = 0.03). hArg did not correlate with ADMA, but correlated with Arg before (r = 0.240, P = 0.02) and after treatment (r = 0.233, P = 0.03). These results suggest that hArg, ADMA and Arg are biochemically familiar with each other, but unrelated to hCys in RA. In PAOD and CAD, ADMA and thCys did not correlate.

Keywords

    Cardiovascular risk, Homoarginine, Homocysteine, Methylation, Plasma, Rheumatoid arthritis

ASJC Scopus subject areas

Cite this

Plasma homoarginine, arginine, asymmetric dimethylarginine and total homocysteine interrelationships in rheumatoid arthritis, coronary artery disease and peripheral artery occlusion disease. / Kayacelebi, A.A.; Willers, J.; Pham, V.V. et al.
In: AMINO ACIDS, Vol. 47, No. 9, 28.09.2015, p. 1885-1891.

Research output: Contribution to journalArticleResearchpeer review

Download
@article{59051af420ce4c2ab4c3afbe8d94dca9,
title = "Plasma homoarginine, arginine, asymmetric dimethylarginine and total homocysteine interrelationships in rheumatoid arthritis, coronary artery disease and peripheral artery occlusion disease",
abstract = "Elevated circulating concentrations of total L-homocysteine (thCys) and free asymmetric dimethylarginine (ADMA) are long-established cardiovascular risk factors. Low circulating L-homoarginine (hArg) concentrations were recently found to be associated with increased cardiovascular morbidity and mortality. The biochemical pathways of these amino acids overlap and share the same cofactor S-adenosylmethionine (SAM). In the present study, we investigated potential associations between hArg, L-arginine (Arg), ADMA and thCys in plasma of patients suffering from rheumatoid arthritis (RA), coronary artery disease (CAD) or peripheral artery occlusive disease (PAOD). In RA, we did not find any correlation between ADMA or hArg and thCys at baseline (n = 100) and after (n = 83) combined add-on supplementation of omega-3 fatty acids, vitamin E, vitamin A, copper, and selenium, or placebo (soy oil). ADMA correlated with Arg at baseline (r = 0.446, P < 0.001) and after treatment (r = 0.246, P = 0.03). hArg did not correlate with ADMA, but correlated with Arg before (r = 0.240, P = 0.02) and after treatment (r = 0.233, P = 0.03). These results suggest that hArg, ADMA and Arg are biochemically familiar with each other, but unrelated to hCys in RA. In PAOD and CAD, ADMA and thCys did not correlate.",
keywords = "Cardiovascular risk, Homoarginine, Homocysteine, Methylation, Plasma, Rheumatoid arthritis",
author = "A.A. Kayacelebi and J. Willers and V.V. Pham and Andreas Hahn and J.Y. Schneider and S. Rothmann and J.C. Fr{\"o}lich and D. Tsikas",
note = "Publisher Copyright: {\textcopyright} 2015 Springer-Verlag. Copyright: Copyright 2016 Elsevier B.V., All rights reserved.",
year = "2015",
month = sep,
day = "28",
doi = "10.1007/s00726-015-1915-3",
language = "English",
volume = "47",
pages = "1885--1891",
journal = "AMINO ACIDS",
issn = "0939-4451",
publisher = "Springer-Verlag Wien",
number = "9",

}

Download

TY - JOUR

T1 - Plasma homoarginine, arginine, asymmetric dimethylarginine and total homocysteine interrelationships in rheumatoid arthritis, coronary artery disease and peripheral artery occlusion disease

AU - Kayacelebi, A.A.

AU - Willers, J.

AU - Pham, V.V.

AU - Hahn, Andreas

AU - Schneider, J.Y.

AU - Rothmann, S.

AU - Frölich, J.C.

AU - Tsikas, D.

N1 - Publisher Copyright: © 2015 Springer-Verlag. Copyright: Copyright 2016 Elsevier B.V., All rights reserved.

PY - 2015/9/28

Y1 - 2015/9/28

N2 - Elevated circulating concentrations of total L-homocysteine (thCys) and free asymmetric dimethylarginine (ADMA) are long-established cardiovascular risk factors. Low circulating L-homoarginine (hArg) concentrations were recently found to be associated with increased cardiovascular morbidity and mortality. The biochemical pathways of these amino acids overlap and share the same cofactor S-adenosylmethionine (SAM). In the present study, we investigated potential associations between hArg, L-arginine (Arg), ADMA and thCys in plasma of patients suffering from rheumatoid arthritis (RA), coronary artery disease (CAD) or peripheral artery occlusive disease (PAOD). In RA, we did not find any correlation between ADMA or hArg and thCys at baseline (n = 100) and after (n = 83) combined add-on supplementation of omega-3 fatty acids, vitamin E, vitamin A, copper, and selenium, or placebo (soy oil). ADMA correlated with Arg at baseline (r = 0.446, P < 0.001) and after treatment (r = 0.246, P = 0.03). hArg did not correlate with ADMA, but correlated with Arg before (r = 0.240, P = 0.02) and after treatment (r = 0.233, P = 0.03). These results suggest that hArg, ADMA and Arg are biochemically familiar with each other, but unrelated to hCys in RA. In PAOD and CAD, ADMA and thCys did not correlate.

AB - Elevated circulating concentrations of total L-homocysteine (thCys) and free asymmetric dimethylarginine (ADMA) are long-established cardiovascular risk factors. Low circulating L-homoarginine (hArg) concentrations were recently found to be associated with increased cardiovascular morbidity and mortality. The biochemical pathways of these amino acids overlap and share the same cofactor S-adenosylmethionine (SAM). In the present study, we investigated potential associations between hArg, L-arginine (Arg), ADMA and thCys in plasma of patients suffering from rheumatoid arthritis (RA), coronary artery disease (CAD) or peripheral artery occlusive disease (PAOD). In RA, we did not find any correlation between ADMA or hArg and thCys at baseline (n = 100) and after (n = 83) combined add-on supplementation of omega-3 fatty acids, vitamin E, vitamin A, copper, and selenium, or placebo (soy oil). ADMA correlated with Arg at baseline (r = 0.446, P < 0.001) and after treatment (r = 0.246, P = 0.03). hArg did not correlate with ADMA, but correlated with Arg before (r = 0.240, P = 0.02) and after treatment (r = 0.233, P = 0.03). These results suggest that hArg, ADMA and Arg are biochemically familiar with each other, but unrelated to hCys in RA. In PAOD and CAD, ADMA and thCys did not correlate.

KW - Cardiovascular risk

KW - Homoarginine

KW - Homocysteine

KW - Methylation

KW - Plasma

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84940446635&partnerID=8YFLogxK

U2 - 10.1007/s00726-015-1915-3

DO - 10.1007/s00726-015-1915-3

M3 - Article

VL - 47

SP - 1885

EP - 1891

JO - AMINO ACIDS

JF - AMINO ACIDS

SN - 0939-4451

IS - 9

ER -

By the same author(s)